Janssen Prods
1 products tracked · names used in filings: Janssen Prods
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 27 Feb 2026🇺🇸 FDA approval
FDA approves Prezcobix (cobicistat, darunavir and cobicistat, darunavir ethanolate): new dosage form
Janssen Prods; NDA220092; New dosage form; tablet, for suspension · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Prezcobix cobicistat, darunavir and cobicistat, darunavir ethanolate | Approved | 2026-02-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.